EUVIMED · CrossrefZeitschrift
Journal of the Advanced Practitioner in Oncology
ISSN 2150-0878 · Harborside Press, LLC
Neueste Artikel
JADPRO Live 2026: APs at the Heart of Cancer Care
Enhancing Radiation Oncology Training for Advanced Practice Providers Through a Standardized Online Curriculum: A Quality Improvement Initiative
Elevation Through Innovation: An Updated Advanced Practice Provider-Led Approach to Outpatient CAR T-Cell Monitoring
Impact of Peer-Developed Education on the Clinical Utility of Liquid Biopsy for Advanced Practitioners
Common Cabozantinib Adverse Events: Management and Impact on Outcomes and Treatment Duration in Advanced Renal Cell Carcinoma, Hepatocellular Carcinoma, and Radioiodine-Refractory Differentiated Thyroid Cancer
Rare Melanomas and Quality of Life: A Report From the Melanoma Research Alliance’s RARE Registry
Immunotherapies in Multiple Myeloma: A Practical Approach to Optimizing Care and Managing Treatment-Related Toxicities
Cyclosporine-Induced Hypertension and Hyperlipidemia: A Practical Guide for Advanced Practice Providers
Peginterferon Alfa-2a for Chronic Myeloid Leukemia in Pregnancy: A Case Report
Melatonin for the Management of Cancer-Related Fatigue in Breast Cancer: An Integrative Review
Imetelstat: A First-in-Class Telomerase Inhibitor for the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes and Anemia
Psychosocial Impact of Ostomies in Women With Colorectal Cancer: An Integrative Review
Obinutuzumab Infusion-Related Reactions: Multicenter Retrospective Evaluation of Incidence, Severity, and Risk Factors
Seamless Navigation of Bispecific Therapies: Optimizing Management and Outpatient Access With a Focus on Coordination
Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin
Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine
The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology
The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine
Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?
Improving Cancer Care Delivery: Learnings for Oncology Nurses and Patient Navigation From a National Quality Survey
Multidisciplinary Tumor Boards and Guiding Patient Care: The AP Role
Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case Series
The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer
Metastatic Melanoma With Leptomeningeal Disease
Advance Care Planning and End-Of-Life Communications: Practical Tips for Oncology Advanced Practitioners
Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor Microenvironment and Barriers to Treatment
The American Cancer Society’s Facts & Figures: 2020 Edition
Secondary Analysis Research
Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
Significance of Human Papillomavirus in Head and Neck Cancers
EUVIMED